We’re all waiting for the release of a viable vaccine for this novel coronavirus to be able to get our lives back. More massive companies are making huge efforts these days to come up with a vaccine, and it seems that at least two of the candidates have 95% efficiency, according to the reports.
It’s also important to note that the FDA allowed for the use of Regeneron’s Covid-19 antibody treatment – this is a huge step that will make it more widely available to patients in need.
More than that, it’s also worth mentioning the fact that there’s one potential treatment for the virus could be found right across the street, at the local pharmacy – this is the common sleep aid melatonin.
AstraZeneca reveals vaccine mistake.
AstraZeneca and the University of Oxford’s coronavirus vaccine’s high efficiency may have been due to a dosing error according to the latest reports.
Euro News notes that in a press release on the vaccine’s efficiency release on Monday, the vaccine candidate had a higher efficiency – of 90% in the group that received a half a dose and then a full dose, according to the official notes.
On the other hand, it seems that the vaccine was just 62% effective in the group that received two full doses.
Mene Pangalos, head of biopharmaceuticals research and development at AstraZeneca, reportedly told Reuters on Monday that some participants received a half dose and then a full dose due to a dosing error.
Pangalos this a “useful mistake” in a later interview with the New York Times, published on Wednesday.
We suggest that you check out the complete original article in order to learn more details about what happened.